Trial Profile
Phase I/IIa trial of Neovasculgen
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 20 Jul 2015
Price :
$35
*
At a glance
- Drugs Vascular endothelial growth factor-165 gene therapy (Neovasculgen) (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- 20 Jul 2015 New trial record